From the Journals

Opioid overdoses tied to lasting cognitive impairment


 

FROM THE JOURNAL OF ADDICTION SCIENCE

Better documentation needed

The variability in symptoms, as well as their timing, present challenges to initial treatment, which often occur before a patient reaches the hospital. This is a vital window because the length of time of inadequate respiration because of opioid overdose is likely to predict the extent of brain injury. The duration of inadequate respiration may not be captured in electronic medical records, and emergency departments don’t typically collect toxicology information, which may lead health care providers to attribute neurocognitive impairments to ongoing drug use rather than an acute anoxic or hypoxic episode. Further neurocognitive damage may have a delayed onset, and better documentation of these events could help physicians determine whether those symptoms stem from the acute event.

Dr. Winstanley and associates called for more research, including prospective case-control studies to identify brain changes following opioid-related overdose.

The authors also suggested that physicians might want to consider screening patients who experience prolonged anoxia or hypoxia for neurocognitive impairments and brain injuries. Dr. Gold agreed.

“Clinicians working with OUD patients should take these data to heart and take a comprehensive history of previous overdoses, loss of consciousness, head trauma, and following up on the history with neuropsychological and other tests of brain function,” Dr. Gold said. “After an assessment, rehabilitation and treatment might then be more personalized and effective.”

Dr. Gold had no relevant financial disclosures.

Pages

Recommended Reading

Biden administration nixes buprenorphine waiver, docs disappointed
MDedge Rheumatology
Opioid-related deaths lower in counties with active cannabis dispensaries
MDedge Rheumatology
Doctors more likely to prescribe opioids to COVID ‘long-haulers,’ raising addiction fears
MDedge Rheumatology
FDA OKs higher-dose naloxone nasal spray for opioid overdose
MDedge Rheumatology
Physician convicted in buprenorphine scheme faces up to 20 years in prison
MDedge Rheumatology
Pfizer halts distribution of stop-smoking pill Chantix
MDedge Rheumatology
Opioid prescribing laws having an impact
MDedge Rheumatology
EDs saw more benzodiazepine overdoses, but fewer patients overall, in 2020
MDedge Rheumatology
‘Deeper dive’ into opioid overdose deaths during COVID pandemic
MDedge Rheumatology
Growing proportion of cardiac arrests in U.S. considered opioid related
MDedge Rheumatology